Health TrialsbyHealthPanel

In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping

ConditionDrug Allergy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14+
SponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

About this trial

Testing a clinical decision tool (BL-Predictor)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

signed informed consnet

Disqualifiers

Use of immunomodulators, antihistamines and corticosteroids

Trial design

Design model

Parallel

Treatments tested in this trial

  • BL-Predicter

    Diagnostic test

    To Clinically validate the BL-Predictor toll by a randomised conytrolled ttrial

Treatment groups

332 Participants
are divided into 2 treatment groups
Group A: BL PredictorExperimental treatment 1 intervention
Group B: controlActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

The main goal of this project is to test a cliniacl decision toll to stratify BL allergic pataients in low and mediaum- anf high-risk

And to carry out a deep dissection of the cellular mechanisms of B cells sensitization and basophil and neutrophil activation in BL-IRs to develop accurate in vitro diagnostic test

Time frame
April 2029- june 2027

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: